Grant Verstandig - May 31, 2022 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Director
Signature
/s/ Andrew Pearce, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
May 31, 2022
Transactions value $
$297,561
Form type
4
Date filed
6/2/2022, 07:42 PM
Previous filing
Mar 28, 2022
Next filing
Jun 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Purchase $107K +47.9K +4.83% $2.23* 1.04M Jun 2, 2022 Direct F1, F2
transaction NEXI Common Stock Purchase $95.8K +40.2K +4.23% $2.38* 991K Jun 1, 2022 Direct F2, F3
transaction NEXI Common Stock Purchase $95.1K +45K +4.97% $2.11* 951K May 31, 2022 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.09 to $2.38, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F2 Excludes 17,376 shares of common stock underlying options that are currently exercisable.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.50, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.03 to $2.46, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.